Evidence map›Paper›PMID 38920634›Full record

ArticleCells2024

D-MAINS: A Deep-Learning Model for the Label-Free Detection of Mitosis, Apoptosis, Interphase, Necrosis, and Senescence in Cancer Cells.

Sarah He, Muhammed Sillah, Aidan R Cole, Apoorva Uboveja, Katherine M Aird, Yu-Chih Chen, Yi-Nan Gong

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Tui: A Multigenerational and Expert-Correctable Tracker for Cellular Dynamics.Computational and structural biotechnology journal · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sarah HeDepartment of Biological Sciences, Carnegie Mellon University, 5000 Forbes Avenue, Pittsburgh, PA 15213, USA.
Muhammed SillahHillman Cancer Center, UPMC, 5115 Center Avenue, Pittsburgh, PA 15232, USA.
Aidan R ColeHillman Cancer Center, UPMC, 5115 Center Avenue, Pittsburgh, PA 15232, USA.
Apoorva UbovejaHillman Cancer Center, UPMC, 5115 Center Avenue, Pittsburgh, PA 15232, USA.
Katherine M AirdHillman Cancer Center, UPMC, 5115 Center Avenue, Pittsburgh, PA 15232, USA.
Yu-Chih ChenHillman Cancer Center, UPMC, 5115 Center Avenue, Pittsburgh, PA 15232, USA.ORCID 0000-0002-3875-4671
Yi-Nan GongHillman Cancer Center, UPMC, 5115 Center Avenue, Pittsburgh, PA 15232, USA.ORCID 0000-0002-3643-4682

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Project 3: Hedgehog Inhibition to Enhance Response to ICI TherapyP50CA272218 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Ronald J Buckanovich, Robert Page Edwards · 2023 to 2026
$11.0M
Metabolic and epigenetic reprogramming in cyclin E high ovarian cancerR01CA259111 · NCI · WISTAR INSTITUTE · PI AIRD, KATHERINE MARIE, SNYDER, NATHANIEL W. · 2021 to 2025
$2.9M
Investigating p16 Loss in Pro-tumorigenic MetabolismR37CA240625 · NCI · WISTAR INSTITUTE · PI AIRD, KATHERINE MARIE · 2020 to 2025
$2.6M
Necrotic survivors and plasma membrane integrity signalingDP2GM146320 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GONG, YI-NAN · 2021 to 2024
$2.3M
Predoctoral Training in Pharmacological Sciences (Resubmission)T32GM133332 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Tija C. Jacob, Francisco Jose Schopfer · 2020 to 2026
$1.8M
Deciphering Cellular Heterogeneity and Inheritability in MigrationR35GM150509 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Yu-Chih Chen · 2023 to 2026
$1.5M
NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA272218NCI NIH HHS R01 CA259111NCI NIH HHS R37 CA240625NIGMS NIH HHS DP2 GM146320NIGMS NIH HHS R35 GM150509NIGMS NIH HHS T32 GM133332NIH HHS DP2GM146320, P30 CA047904, P50 CA272218, R35 GM150509 ,R37CA240625, R01CA259111NIH HHS T32GM133332Ovarian Cancer Research Alliance MIG-2023-2-1018
6 · The paper itself

Abstract

backgroundIdentifying cells engaged in fundamental cellular processes, such as proliferation or living/death statuses, is pivotal across numerous research fields. However, prevailing methods relying on molecular biomarkers are constrained by high costs, limited specificity, protracted sample preparation, and reliance on fluorescence imaging.

methodsBased on cellular morphology in phase contrast images, we developed a deep-learning model named Detector of Mitosis, Apoptosis, Interphase, Necrosis, and Senescence (D-MAINS).

resultsD-MAINS utilizes machine learning and image processing techniques, enabling swift and label-free categorization of cell death, division, and senescence at a single-cell resolution. Impressively, D-MAINS achieved an accuracy of 96.4 ± 0.5% and was validated with established molecular biomarkers. D-MAINS underwent rigorous testing under varied conditions not initially present in the training dataset. It demonstrated proficiency across diverse scenarios, encompassing additional cell lines, drug treatments, and distinct microscopes with different objective lenses and magnifications, affirming the robustness and adaptability of D-MAINS across multiple experimental setups.

conclusionsD-MAINS is an example showcasing the feasibility of a low-cost, rapid, and label-free methodology for distinguishing various cellular states. Its versatility makes it a promising tool applicable across a broad spectrum of biomedical research contexts, particularly in cell death and oncology studies.

Indexed as

ApoptosisCellular SenescenceDeep LearningInterphaseMitosisNecrosisCell Line, TumorHumansImage Processing, Computer-AssistedNeoplasmscell deathimage processinginterphaselabel freemachine learningmitosissenescence

Identifiers

PMID38920634
PMCPMC11205186

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.